Patient monitoring should include: Baseline lipid panel, hemoglobin A1c, and liver function tests Blood pressure monitoring (GLP-1 agents typically reduce systolic BP by 3-5 mmHg) [10] Assessment for gastrointestinal adverse effects during dose titration Evaluation for contraindications (personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2) [1] [3] Monitoring for gallbladder disease (increased risk with rapid weight loss) In patients with diabetes and retinopathy, monitoring for worsening eye symptoms, particularly with rapid glycemic improvement Renal function assessment, especially if severe gastrointestinal symptoms cause dehydration Patients should seek immediate medical attention for severe abdominal pain, which may indicate pancreatitisa rare but serious adverse effect

We personalize your dose, troubleshoot side effects, build a protein-forward nutrition plan, and coach you on movement and habitsso you feel the difference in weeks and sustain it for months to come
Additionally, semaglutide is used to lower the risk of kidney function decline in patients with type 2 diabetes and chronic kidney disease
Expression of the stress response genes RD29A ( Response-to-Dehydration 29A ), COR15A ( Cold-Regulated 15A ), KIN1 ( Kinesin 1 ) and ABI2 ( Abscisic acid Insensitive 2 ) was increased in transgenic plants compared to wild type
doi: 10.1161/CIR.0000000000000597 30
-20C, 1 month (sealed storage, away from moisture) Solvent & Solubility In Vitro : H 2 O : 100 mg/mL ( 70.45 mM ) DMSO : 50 mg/mL ( 35.22 mM